Certara, Inc. (NASDAQ:CERT) Receives $19.81 Consensus Target Price from Analysts

Shares of Certara, Inc. (NASDAQ:CERT) have been assigned an average recommendation of “Hold” from the eleven brokerages that are currently covering the company, MarketBeat reports. Seven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $19.44.

A number of equities research analysts recently weighed in on CERT shares. KeyCorp decreased their price objective on Certara from $23.00 to $20.00 and set an “overweight” rating for the company in a research note on Thursday. JMP Securities reaffirmed a “market perform” rating on shares of Certara in a report on Wednesday. Finally, Barclays decreased their price objective on Certara from $18.00 to $16.00 and set an “equal weight” rating for the company in a report on Friday, June 28th.

Hedge Funds Weigh In On Certara

A number of hedge funds have recently made changes to their positions in the stock. Pineridge Advisors LLC acquired a new position in shares of Certara in the fourth quarter worth $28,000. Global Retirement Partners LLC grew its stake in Certara by 5,306.3% during the 1st quarter. Global Retirement Partners LLC now owns 1,730 shares of the company’s stock worth $31,000 after purchasing an additional 1,698 shares in the last quarter. YHB Investment Advisors Inc. purchased a new stake in Certara during the 1st quarter worth about $47,000. Natixis Advisors L.P. raised its position in Certara by 13.4% in the 3rd quarter. Natixis Advisors L.P. now owns 15,136 shares of the company’s stock valued at $220,000 after purchasing an additional 1,791 shares in the last quarter. Finally, Pacer Advisors Inc. boosted its stake in shares of Certara by 1,704.0% in the 4th quarter. Pacer Advisors Inc. now owns 12,754 shares of the company’s stock valued at $224,000 after buying an additional 12,047 shares during the period. Hedge funds and other institutional investors own 73.96% of the company’s stock.

Certara Stock Up 8.9 %

NASDAQ:CERT opened at $15.12 on Tuesday. The company has a market cap of $2.43 billion, a price-to-earnings ratio of -38.77, a price-to-earnings-growth ratio of 4.93 and a beta of 1.52. Certara has a twelve month low of $11.81 and a twelve month high of $19.87. The company has a current ratio of 3.26, a quick ratio of 3.26 and a debt-to-equity ratio of 0.27. The stock has a fifty day simple moving average of $15.53 and a 200-day simple moving average of $16.69.

Certara (NASDAQ:CERT) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.01). The firm had revenue of $96.65 million during the quarter, compared to the consensus estimate of $94.48 million. Certara had a positive return on equity of 4.08% and a negative net margin of 17.02%. Analysts anticipate that Certara will post 0.28 EPS for the current year.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.